[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631949":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":10,"responsibleParty":18,"collaborators":22,"id":25,"slug":26,"hasResults":27,"nctId":28,"briefTitle":29,"officialTitle":30,"acronym":10,"eligibilityCriteria":31,"healthyVolunteers":27,"sex":32,"minAge":33,"maxAge":10,"enrollmentInfo":34,"targetDuration":10,"studyType":37,"phases":10,"briefSummary":38,"conditions":39,"keywords":44,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":10},{"fullName":5,"class":6},"Gaziantep Islam Science and Technology University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients diagnosed with Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) and neurogenic lower uri",null,"Adults with spinal cord injury (SCI) or multiple sclerosis (MS) who have neurogenic lower urinary tract dysfunction will be included. Participants will complete the Turkish version of the Neurogenic Bladder Symptom Score Short Form (NBSS-SF), the King's Health Questionnaire (KHQ), and the Short Form-12 (SF-12). In clinically stable eligible participants, the Turkish NBSS-SF will be re-administered after 7 to 14 days to assess test-retest reliability.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Bengisu Tufekci, PT, PhD, Asst.Prof.","CONTACT","05055764104","tufekci.bengisu@gmail.com",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Bengisu Tüfekçi","Assistant Professor",[23],{"name":24,"class":6},"Ufuk University","100631949","turkish-version-of-the-neurogenic-bladder-symptom-score-short-form-100631949",false,"NCT07507331","Turkish Version of the Neurogenic Bladder Symptom Score Short Form","Turkish Version of the Neurogenic Bladder Symptom Score Short Form: Cross-Cultural Adaptation and Validation-Reliability Study","Inclusion Criteria:\n\n* Being ≥18 years old\n\n  * Having a diagnosis of Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) and neurogenic lower urinary tract dysfunction\n  * Being able to read and understand Turkish and have the cognitive ability to independently complete questionnaires\n  * Can be included with any bladder management method (spontaneous voiding, CIC, permanent catheter, condom catheter, reconstruction\u002Fdiversion etc.)\n  * Volunteering and signing informed consent\n\nExclusion Criteria:\n\n* Having an active urinary tract infection (UTI)\n* Having undergone urological surgery in the last month\n* Reporting changes in bladder\u002Furinary function between the first and second applications (surgery, UTI, change in bladder medication)\n* Having a significant recent change in general health status\n* Having a spinal cord injury (SCI) in the spinal shock phase\n* Having experienced a relapse of Multiple Sclerosis (MS) within the last 3 months.","ALL","18 Years",{"count":35,"type":36},120,"ESTIMATED","OBSERVATIONAL","This observational study aims to evaluate the cross-cultural adaptation and psychometric properties of the Turkish version of the Neurogenic Bladder Symptom Score Short Form (NBSS-SF) in adults with spinal cord injury or multiple sclerosis who have neurogenic lower urinary tract dysfunction. Neurogenic bladder symptoms, such as urinary incontinence, urgency, and difficulties with urine storage or emptying, may negatively affect daily functioning and quality of life. In this study, the validity and reliability of the Turkish NBSS-SF will be examined, and convergent validity will be assessed through its relationship with the King's Health Questionnaire (KHQ) and the Short Form-12 (SF-12). In eligible participants, the scale will be administered again after 7 to 14 days. The aim of the study is to provide a valid and reliable Turkish patient-reported outcome measure for use in clinical practice and research.",[40,41,42,43],"Neurogenic Bladder Disorder","Spinal Cord Injury","Multiple Sclerosis","Lower Urinary Track Symptoms",[45,46,41,42],"Neurogenic Bladder","Neurogenic Bladder Symptom Score- Short Form Validation","NOT_YET_RECRUITING","2026-04-07",{"date":50,"type":51},"2026-04-13","ACTUAL",{"date":53,"type":36},"2026-03-27",{"date":55,"type":36},"2026-05",{"name":5,"class":6}]